Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging—a systematic review and meta-analysis

YJ Lee, JM Lee, JS Lee, HY Lee, BH Park, YH Kim… - Radiology, 2015 - pubs.rsna.org
Purpose To perform a systematic review and meta-analysis of the diagnostic performance of
computed tomography (CT) and magnetic resonance (MR) imaging as noninvasive …

[HTML][HTML] Primovist, Eovist: what to expect?

BE Van Beers, CM Pastor, HK Hussain - Journal of hepatology, 2012 - Elsevier
Gadolinium ethoxybenzyl dimeglumine (Gd-EOB-DTPA, Primovist® in Europe and Eovist®
in the USA) is a liver-specific magnetic resonance imaging contrast agent that has up to 50 …

Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a …

A Hiraoka, K Michitaka, T Kumada, N Izumi, M Kadoya… - Liver cancer, 2017 - karger.com
Abstract Background/Aim: Recently, albumin-bilirubin (ALBI) scoring/grading, consisting of
only albumin and total bilirubin, has been proposed. We examined the efficacy of this …

Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: a multicenter analysis

A Hiraoka, T Kumada, K Tsuji, K Takaguchi… - Liver cancer, 2019 - karger.com
Background/Aim: The frequency of hepatocellular carcinoma (HCC) in patients with good
hepatic reserve function has been increasing in Japan along with the progression of antiviral …

Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with child‐Pugh class a or B liver function in …

T Tanaka, A Hiraoka, T Tada, M Hirooka… - Hepatology …, 2022 - Wiley Online Library
Abstract Background/Aim Atezolizumab plus bevacizumab (Atez/Bev) treatment is
recommended for unresechepatocellular carcinoma (u‐HCC) patients classified as Child …

Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma

RF Hanna, VZ Miloushev, A Tang, LA Finklestone… - Abdominal …, 2016 - Springer
Purpose To compare the per-lesion sensitivity and positive predictive value (PPV) of
ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) …

Imaging techniques for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis

R Chou, C Cuevas, R Fu, B Devine… - Annals of internal …, 2015 - acpjournals.org
This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Background: Several imaging modalities are available for diagnosis of …

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis

A Hiraoka, T Kumada, M Atsukawa, M Hirooka… - Cancer …, 2019 - Wiley Online Library
Background/aim We assessed suitable factors indicating newly developed lenvatinib (LEN)
treatment for unresectable hepatocellular carcinoma (u‐HCC) by investigating real‐world …

Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality

MS Davenport, BL Viglianti, MM Al-Hawary, EM Caoili… - Radiology, 2013 - pubs.rsna.org
Purpose To determine whether acute transient dyspnea and/or arterial phase image
degradation occurs more or less often after intravenous administration of gadoxetate …

Competitive advantage of PET/MRI

H Jadvar, PM Colletti - European journal of radiology, 2014 - Elsevier
Multimodality imaging has made great strides in the imaging evaluation of patients with a
variety of diseases. Positron emission tomography/computed tomography (PET/CT) is now …